SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Columbia Large Cap Index Fund Institutional 2 Class (CLXRX) trades at a trailing P/E of 21.7. Trailing earnings yield is 4.60%. PEG 0.04 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (21.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.04); earnings yield beats bond yields (4.60%).
- PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.60% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 65/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CLXRX
Valuation Multiples
P/E (TTM)21.7
Forward P/EN/A
PEG Ratio0.04
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.66
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.63
Book Value / Share$0.00
Revenue / Share$34.50
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.60%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$4.44 |
$92.26B |
$11.22B |
12.2% |
| 2015 |
$6.20 |
$80.7B |
$15.66B |
19.4% |
| 2016 |
$5.03 |
$79.43B |
$12.71B |
16% |
| 2017 |
$5.64 |
$92.07B |
$14.25B |
15.5% |
| 2018 |
$5.36 |
$91.43B |
$13.55B |
14.8% |
| 2019 |
$1.84 |
$85.69B |
$4.66B |
5.4% |
| 2020 |
$4.53 |
$79.59B |
$11.46B |
14.4% |
| 2021 |
$3.36 |
$83.96B |
$8.49B |
10.1% |
| 2022 |
$0.37 |
$100.66B |
$924M |
0.9% |
| 2023 |
$2.63 |
$87.17B |
$6.66B |
7.6% |
